About
Vaccines using purely synthetic components to activate T-cells of the immune system
Areas of Focus
Categories
Vaccine
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
162
By Phase
PHASE1/PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05633446Lead Sponsor
Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)
PHASE1/PHASE2Not yet recruiting
110 participants
Started: Sep 1, 2025 · Completed: Dec 1, 2026
NCT05113862Lead Sponsor
A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2
PHASE1Completed
26 participants
Started: Jan 10, 2022 · Completed: Sep 15, 2022
NCT04935801Lead Sponsor
A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus
PHASE1Completed
26 participants
Started: Aug 2, 2021 · Completed: Sep 15, 2022
Locations (1)
Headquarters
Abingdon, UK
Map
Loading map...